Astrocyte Epigenetic Memory And Neuroinflammation

Astrocyte epigenetic inflammatory memory promotes chronic neuroinflammation and CNS pathology.

In this post, we will discuss what astrocyte epigenetic memory is, what drives it at a mechanistic level, which conditions and environmental exposures overlap with it, and what you can do about it.

---

Basics Of Astrocyte Epigenetic Memory

Astrocytes are the most abundant glial cells in the central nervous system (CNS), representing over 20% of total glial cells and covering the CNS in a continuous, non-overlapping manner. R

They perform critical functions including metabolic support, blood-brain barrier (BBB) regulation, and neurotransmitter clearance. R

Astrocyte epigenetic memory refers to lasting changes in gene expression driven by epigenetic modifications.

These modifications include DNA methylation, histone modifications, and chromatin remodeling. R

Unlike genetic mutations, epigenetic changes do not alter the DNA sequence itself.

Instead, they modify how genes are turned on or off in response to environmental stimuli.

Inflammatory stimuli can trigger epigenetic reprogramming in astrocytes.

This creates a long-term memory of prior inflammatory exposures.

When re-exposed to similar stimuli, these astrocytes respond with heightened inflammation. R

This epigenetic memory can persist for months or even years after the initial trigger.

It represents a form of maladaptive plasticity in the CNS.

Astrocyte epigenetic memory contributes to chronic neuroinflammation in multiple disease states.

These include multiple sclerosis (MS), Alzheimer's disease (AD), and traumatic brain injury (TBI). R

The memory is not merely a passive record but actively shapes future immune responses.

It can amplify damage through exaggerated inflammatory cascades.

Understanding this mechanism is key to treating chronic inflammatory brain conditions.

What Causes Astrocyte Epigenetic Memory

Inflammatory cytokines like IL-1β and TNF-α can trigger astrocyte epigenetic reprogramming. R

These cytokines are released by activated microglia during neuroinflammation and are capable of stimulating astrogliosis in vivo. R

Co-stimulation with IL-1β and TNF-α has been demonstrated to be a more potent trigger of astrocyte reactivity than either cytokine independently. R

Glucocorticoid receptor NR3C1 acts as a key regulator of astrocyte epigenetic inflammatory programming. R

Loss of NR3C1 in astrocytes during early life establishes lasting epigenetic memory that heightens neuroinflammation. R

The metabolic enzyme ATP-citrate lyase (ACLY) produces acetyl-CoA for histone acetylation by p300. R

ACLY/p300+ astrocytes represent an epigenetically controlled memory subset that promotes CNS pathology. R

Chronic stress exposure can drive astrocyte epigenetic changes via glucocorticoid signaling. R

TNF-α plays a pivotal role in LPS-upregulated astrocyte activation and proliferation. R

Environmental toxins like mold metabolites may induce astrocyte epigenetic reprogramming. R

Persistent viral infections can trigger astrocyte epigenetic memory through chronic immune activation. R

Traumatic brain injury initiates astrocyte reactivity that can become epigenetically fixed. R

Aging is associated with accumulated astrocyte epigenetic alterations that promote neuroinflammation. R

Genetic polymorphisms in epigenetic regulators may predispose individuals to maladaptive astrocyte memory. R

Lifestyle factors like poor sleep and diet can exacerbate astrocyte epigenetic dysregulation. R

How Astrocytes Work / Creates The Problem

Astrocytes maintain homeostasis in the CNS through glutamate uptake, potassium buffering, and metabolic support to neurons. R

Astrocytes are primarily responsible for glutamate uptake, removing about 90% of all released glutamate in the CNS. R

Na+-dependent glutamate transporters (EAAT1 and EAAT2) mediate the bulk of glutamate clearance in the adult dorsal forebrain. R

They form the glymphatic system that clears metabolic waste during sleep via aquaporin-4 (AQP4) channels. R

AQP4 is abundantly expressed in the endfeet of astrocytes around small vessels and is essential for the clearance of waste products from the brain. R

AQP4-dependent glymphatic solute transport in the rodent brain has been validated across multiple laboratories. R

Loss of AQP4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation. R

Astrocytes regulate blood-brain barrier (BBB) permeability through endfeet contacts with cerebral vasculature. R

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. R

VEGF-mediated disruption of endothelial CLDN5 promotes blood-brain barrier breakdown. R

They secrete trophic factors that support neuronal survival and synaptic plasticity. R

Under inflammatory conditions, astrocytes become reactive (astrocytosis) and change morphology and function. R

Reactive astrocytes upregulate intermediate filaments like GFAP and vimentin. R

GFAP is a well-established astrocytic biomarker for the diagnosis, monitoring and outcome prediction of traumatic brain injury. R

They release pro-inflammatory cytokines, chemokines, and reactive oxygen species. R

Astrocytes modulate immune cell infiltration into the CNS by expressing adhesion molecules and chemokines. R

They can either promote or resolve inflammation depending on their activation state and epigenetic programming. R

In chronic inflammation, astrocytes develop a pro-inflammatory phenotype that persists via epigenetic memory. R

This maladaptive astrocyte reactivity contributes to blood-brain barrier dysfunction and excitotoxicity. R

Epigenetically primed astrocytes fail to restore homeostasis after inflammatory challenges. R

Instead, they perpetuate a cycle of neuroinflammation and neuronal damage. R

The epigenetic memory creates a lowered threshold for future inflammatory responses. R

This means even minor triggers can reactivate pathogenic astrocyte programs. R

Over time, this drives progressive CNS pathology in conditions like multiple sclerosis and Alzheimer's disease. R

Targeting astrocyte epigenetic memory could break this cycle of chronic neuroinflammation. R

Astrocyte Epigenetic Memory And Overlapping Conditions

Astrocyte epigenetic memory is observed in multiple sclerosis (MS) lesions with increased ACLY+p300+ astrocytes. R

In experimental autoimmune encephalomyelitis (EAE) models, astrocyte epigenetic memory promotes CNS pathology. R

Genetic inactivation of ACLY+p300+ astrocytes ameliorates EAE in mouse models. R

The pro-inflammatory memory phenotype is detected in human astrocytes in vitro and in chronic multiple sclerosis lesions. R

Astrocyte epigenetic memory contributes to Alzheimer's disease (AD) pathogenesis through neuroinflammation. R

Aβ aggregates engage RAGE or TLRs on astrocytes, triggering inflammatory response via the NF-κB pathway. R

Traumatic brain injury (TBI) shows persistent astrocyte reactivity that may become epigenetically fixed. R

TBI-mediated NF-κB activation in astrocytes impairs their homeostatic functions and amplifies the post-traumatic neuroimmune response. R

Astrocyte activation persists one year after TBI, showing a dynamic shift from inflammation to neurodegeneration. R

Long COVID involves astrocyte dysfunction that may relate to epigenetic memory mechanisms. R

Postural orthostatic tachycardia syndrome (POTS) may involve astrocyte-mediated neuroinflammation. R

Mast cell activation syndrome (MCAS) can trigger astrocyte reactivity through histamine and tryptase. R

Chronic inflammatory response syndrome (CIRS) from mold exposure may induce astrocyte epigenetic reprogramming. R

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) shows neuroinflammatory components. R

Astrocyte epigenetic memory may contribute to neurodegeneration in Parkinson's and Huntington's diseases. R

Stroke recovery is impaired by persistent astrocyte reactivity and glial scar formation. R

Reactive astrocytes restrict the lesion area to protect spared tissue from further damage. R

Epigenetic astrocyte memory creates a common pathway linking diverse chronic inflammatory conditions. R

This explains why patients often experience overlapping symptoms across seemingly distinct disorders. R

Targeting this shared mechanism could benefit multiple condition presentations simultaneously. R

How To Improve Astrocyte Epigenetic Memory

Supporting healthy glucocorticoid receptor signaling may help maintain NR3C1's protective effects on astrocyte epigenetics. R

Adequate sleep is essential for glymphatic function and astrocyte homeostasis. R

Sleep drives the glymphatic clearance, and the difference in glymphatic flux between night and day is abolished in AQP4 knockout mice. R

Stress reduction techniques like mindfulness and breathing exercises can lower inflammatory cytokine exposure. R

Anti-inflammatory diets rich in omega-3 fatty acids and polyphenols may reduce astrocyte activation triggers. R

Regular exercise promotes astrocyte health and reduces systemic inflammation. R

Certain supplements may support astrocyte function and epigenetic regulation. R

Magnesium Glycinate supports NMDA receptor function and reduces excitotoxic stress on astrocytes. R

N-Acetylcysteine (NAC) provides glutathione precursor for antioxidant defense in astrocytes. R

Omega-3 Fish Oil reduces pro-inflammatory cytokine production that can trigger astrocyte reactivity. R

Curcumin inhibits NF-kB pathway activation in astrocytes and reduces neuroinflammation. R

Resveratrol activates sirtuin pathways that regulate histone acetylation and epigenetic modifications. R

Green Tea Extract (EGCG) modulates astrocyte activation and reduces inflammatory mediator release. R

Vitamin D regulates immune function and may modulate astrocyte reactivity through VDR signaling. R

B-Complex Vitamins support methylation cycles involved in epigenetic regulation. R

Zinc is essential for glucocorticoid receptor function and NR3C1 signaling. R

Probiotics and prebiotics support gut-brain axis communication that influences astrocyte function. R

Intermittent fasting may promote autophagy and cellular cleanup in astrocytes. R

Ketogenic diet provides alternative fuel that may reduce inflammatory astrocyte activation. R

Cold exposure and hormetic stressors can activate adaptive stress response pathways in astrocytes. R

Grounding or earthing may reduce inflammation and support autonomic nervous system balance. R

Avoiding environmental toxins like mold and heavy metals prevents astrocyte epigenetic triggers. R

Addressing chronic infections reduces persistent immune activation that can imprint astrocyte memory. R

Working with a practitioner to identify and remove individual inflammatory triggers is essential. R

Consistent application of these strategies over time may help reset maladaptive astrocyte epigenetic programs. R

Individual responses vary based on genetics, duration of condition, and coexisting factors. R

Professional guidance is recommended for complex cases involving multiple overlapping conditions. R

What To Stay Away From

Chronic stress and poor stress management exacerbate astrocyte epigenetic reprogramming. R

High sugar and processed food diets increase systemic inflammation and astrocyte reactivity. R

Excessive alcohol consumption impairs astrocyte function and increases neuroinflammation. R

Smoking and tobacco use introduce toxins that trigger astrocyte activation and oxidative stress. R

Sedentary lifestyle reduces glymphatic clearance and promotes astrocyte dysfunction. R

Poor sleep hygiene disrupts circadian rhythms and increases inflammatory cytokine exposure. R

Environmental mold exposure can induce astrocyte epigenetic reprogramming through mycotoxins. R

Heavy metal exposure (lead, mercury, cadmium) activates astrocytes and promotes neuroinflammation. R

Artificial sweeteners and food additives may trigger mast cell activation that affects astrocytes. R

Excessive caffeine consumption can increase anxiety and stress hormone production. R

Night shift work and circadian disruption worsen inflammatory responses in astrocytes. R

Social isolation and loneliness increase inflammatory markers that affect astrocyte function. R

Chronic use of NSAIDs may impair gut barrier function and increase LPS translocation. R

Excessive iron supplementation can promote oxidative stress in astrocytes. R

High histamine foods may trigger mast cell activation that influences astrocyte reactivity. R

Electromagnetic field (EMF) exposure may increase cellular stress in astrocytes. R

Blue light exposure at night disrupts melatonin production and increases inflammation. R

Chronic antibiotic use can disrupt microbiome balance and affect gut-brain axis signaling. R

Polypharmacy and unnecessary medications increase toxic burden on astrocytes. R

Ignoring persistent symptoms allows astrocyte epigenetic memory to strengthen over time. R

Self-diagnosis and treatment without proper testing can lead to ineffective interventions. R

Isolating oneself from support systems increases stress burden that affects astrocytes. R

Avoiding professional guidance for complex cases may prolong suffering and prevent improvement. R

Staying in toxic relationships or environments maintains chronic stress exposure. R

Neglecting foundational health practices like hydration and nutrition undermines recovery efforts. R

Expecting quick fixes ignores the time needed to reset epigenetic programs. R

Comparing oneself to others' healing journeys creates unnecessary stress and disappointment. R

Giving up on improvement efforts prevents potential progress in astrocyte function. R

Testing

Imaging — PET scans with specific tracers can assess astrocyte activation and neuroinflammation. R

MRS — Magnetic resonance spectroscopy can detect biomarkers of neuroinflammation and metabolic dysfunction. R

CSF analysis — Cerebrospinal fluid analysis can measure inflammatory cytokines and markers of astrocyte activation. R

Blood And Urine Markers

Tryptase — Mast cell degranulation marker that can activate astrocytes. R

Histamine — Mediator that influences astrocyte reactivity and neuroinflammation. R

IL-6 — Pro-inflammatory cytokine implicated in astrocyte activation. R

TNF-α — Cytokine that drives astrocyte reactivity and inflammatory memory. R

GFAP — Glial fibrillary acidic protein, marker of astrocyte activation. R

S100B — Astrocyte-derived protein indicating glial injury or activation. R

VCAM-1 — Vascular adhesion molecule involved in immune cell trafficking to CNS. R

CCL2/MCP-1 — Chemokine that recruits monocytes and influences astrocyte function. R

Oxidized LDL — Marker of oxidative stress that can activate astrocytes. R

8-OHdG — Marker of DNA oxidative damage in inflammatory conditions. R

Homocysteine — Elevated in inflammation and affects methylation cycles. R

Vitamin D, 25-OH — Regulates immune function and astrocyte reactivity. R

Magnesium — Essential for NMDA receptor function and astrocyte homeostasis. R

Zinc — Critical for glucocorticoid receptor signaling and NR3C1 function. R

Copper/Zinc ratio — Imbalance can indicate oxidative stress and inflammation. R

Ceruloplasmin — Copper-binding protein involved in oxidative stress regulation. R

Functional Lab Panels

I use the Immune-zoomer to assess mast cell activation, autoantibodies, and immune reactivity relevant to astrocyte epigenetic memory. R

I use the Gut-zoomer to assess microbiome balance, pathogens, and intestinal permeability that can trigger astrocyte reactivity. R

I use the Toxin-zoomer to assess mold metabolites, heavy metals, and environmental chemicals that may induce astrocyte epigenetic reprogramming. R

I use the Cellular-zoomer to assess oxidative stress, mitochondrial function, and methylation status relevant to astrocyte epigenetics. R

I use the Methylation genetics to assess MTHFR, MTR, MTRR, COMT, BHMT and methylation cycle variants that influence epigenetic regulation. R

Provocation / Elimination Testing

Elimination diets targeting high-histamine foods can help identify mast cell triggers that influence astrocytes. R

Mold avoidance and environmental testing can reduce exposures that trigger astrocyte epigenetic memory. R

Stress challenge tests may reveal dysregulation in HPA axis and glucocorticoid signaling affecting astrocytes. R

Food sensitivity testing can identify dietary triggers of mast cell activation and astrocyte reactivity. R

Gluten elimination may be warranted in cases of suspected non-celiac gluten sensitivity affecting neuroinflammation. R

Dairy elimination can help assess casein or whey protein influences on immune activation and astrocytes. R

Low-oxalate diet may be considered if oxalate sensitivity contributes to mast cell activation and astrocyte reactivity. R

Salicylate sensitivity testing can identify triggers of mast cell degranulation that influence astrocyte function. R

Histamine challenge or diamine oxidase (DAO) testing can assess histamine intolerance that affects astrocytes. R

LPS (endotoxin) challenge testing may reveal heightened immune reactivity that primes astrocyte memory. R

Vagal tone assessment can indicate autonomic nervous system balance that influences astrocyte function. R

Exercise tolerance testing can reveal dysautonomia that may relate to astrocyte-mediated neuroinflammation. R

Orthostatic testing can assess POTS phenotypes that may involve astrocyte dysregulation. R

Cognitive testing can measure neurocognitive effects of chronic astrocyte activation and neuroinflammation. R

Quantitative EEG (qEEG) can assess brain activity patterns altered by chronic neuroinflammation. R

Heart rate variability (HRV) monitoring can assess autonomic nervous system balance relevant to astrocyte function. R

Sleep studies can identify sleep disorders that impair glymphatic clearance and astrocyte homeostasis. R

Breath testing for SIBO or small intestinal fungal overgrowth (SIFO) can identify gut triggers of astrocyte reactivity. R

Urine organic acids testing can assess metabolic dysfunction and methylation status relevant to epigenetics. R

Stool testing for pathogens, parasites, and dysbiosis can identify gut triggers of immune activation affecting astrocytes. R

Food antibody testing (IgG, IgA, IgE) can identify dietary triggers of immune activation that influence astrocytes. R

Environmental toxin testing for mold, heavy metals, and chemicals can identify astrocyte epigenetic triggers. R

Genetic testing for APOE status can assess Alzheimer's disease risk related to astrocyte function. R

Telomere length testing can assess cellular aging and stress burden that affects astrocytes. R

Microbiome testing via stool analysis can assess gut-brain axis communication that influences astrocyte function. R

Viral antibody panels can identify persistent infections that may trigger astrocyte epigenetic memory. R

Lyme disease and co-infection testing can assess chronic infections that drive neuroinflammation and astrocyte reactivity. R

Bartonella and related pathogen testing can identify stealth infections that affect astrocytes and neuroinflammation. R

Mycotoxin urine testing can assess exposure to mold metabolites that induce astrocyte epigenetic reprogramming. R

Heavy metal urine or blood testing can assess toxin burden that activates astrocytes and promotes neuroinflammation. R

Environmental chemical panels can assess exposure to pesticides, plastics, and other toxins that influence astrocyte function. R

Mechanisms Of Action

Simple

Astrocyte epigenetic memory involves lasting changes in gene expression without altering DNA sequence. R

Inflammatory triggers cause astrocytes to modify histone proteins that control gene accessibility. R

DNA methylation patterns shift to lock astrocytes into pro-inflammatory states. R

Chromatin structure opens up at inflammatory genes, making them easier to activate in the future. R

Acetyl-CoA produced by ACLY provides building blocks for histone acetylation that promotes inflammatory gene expression. R

p300 enzyme adds acetyl groups to histones, increasing inflammatory gene accessibility. R

Glucocorticoid receptor NR3C1 normally limits inflammatory gene accessibility in astrocytes. R

When NR3C1 function is impaired, astrocytes become hyper-responsive to inflammatory triggers. R

Once epigenetic memory is established, even minor stimuli trigger exaggerated inflammatory responses. R

This creates a self-perpetuating cycle of neuroinflammation that becomes progressively harder to break. R

Advanced

Histone Acetylation — ACLY-generated acetyl-CoA serves as substrate for p300/CBP histone acetyltransferases. R

Increased H3K27ac at enhancers and promoters of pro-inflammatory genes amplifies transcription upon restimulation. R

Inhibition of ACLY or p300 reduces astrocyte inflammatory memory and ameliorates EAE pathology. R

DNA Methylation — Inflammatory cytokines can alter DNMT activity, shifting DNA methylation patterns at immune regulatory regions. R

Hypermethylation at anti-inflammatory gene promoters silences protective programs in astrocytes. R

Hypomethylation at pro-inflammatory loci maintains accessibility for future activation. R

These patterns persist through cell divisions, representing true epigenetic memory. R

Chromatin Remodeling — Chromatin remodelers reposition nucleosomes to alter gene accessibility. R

Pro-inflammatory transcription factors establish stable binding at chromatin sites during initial activation. R

These binding events become self-reinforcing through positive feedback loops involving p300 recruitment. R

NR3C1 Signaling — Glucocorticoid receptor NR3C1 recruits repressive complexes to inflammatory gene loci. R

NR3C1 limits chromatin accessibility at pro-inflammatory enhancers through tethering to negative GRE elements. R

Early-life NR3C1 deletion allows premature chromatin opening that persists into adulthood. R

NR3C1 target genes overlap with MS-associated genes, suggesting clinical relevance in humans. R

Type II Interferon Pathway — NR3C1-deficient astrocytes show hyperactivation of IFN-γ signaling upon immune challenge. R

STAT1 phosphorylation and downstream ISG expression are exaggerated in epigenetically primed astrocytes. R

IL-2/STAT5 and IL-6 pathways also show enhanced activation in EAE models with astrocyte NR3C1 loss. R

AQP4 Dysregulation — Astrocyte epigenetic memory affects aquaporin-4 expression in glymphatic system. R

AQP4 is abundantly expressed in the endfeet of astrocytes around small vessels. R

Loss of AQP4 results in glymphatic system dysfunction via brain-wide interstitial fluid stagnation. R

Impaired glymphatic clearance allows metabolic waste accumulation that perpetuates neuroinflammation. R

AQP4 mislocalization observed in Alzheimer's disease and traumatic brain injury may reflect epigenetic changes. R

Glutamate Excitotoxicity — Epigenetically primed astrocytes show altered glutamate transporter expression. R

EAAT1 and EAAT2 downregulation impairs glutamate clearance. R

GLT-1 is responsible for approximately 90% of glutamate uptake in the adult dorsal forebrain. R

Extracellular glutamate accumulation damages neurons and promotes further astrocyte reactivity. R

Blood-Brain Barrier Dysfunction — Astrocyte endfeet control BBB permeability through VEGF and angiopoietin signaling. R

Astrocyte-derived VEGF-A drives BBB disruption in CNS inflammatory disease. R

Pro-inflammatory astrocytes disrupt tight junctions through matrix metalloproteinase release. R

BBB breakdown allows peripheral immune cell entry that amplifies CNS inflammation. R

VEGF-mediated disruption of endothelial CLDN5 promotes blood-brain barrier breakdown. R

Genetics

NR3C1

The glucocorticoid receptor gene encodes the protein formerly known as the glucocorticoid receptor. R

NR3C1 mediates anti-inflammatory effects of endogenous and synthetic glucocorticoids. R

Mutations or polymorphisms in NR3C1 can alter glucocorticoid sensitivity and affect inflammatory responses. R

Some NR3C1 variants are associated with increased risk of autoimmune conditions and neuroinflammation. R

rs4149268 — Variant associated with altered glucocorticoid responsiveness. R

rs2963155 — Variant in promoter region may affect NR3C1 expression levels. R

ACLY

ATP-citrate lyase encodes the enzyme that produces acetyl-CoA in the cytosol. R

ACLY is essential for histone acetylation and epigenetic regulation of inflammatory genes. R

Polymorphisms may influence individual susceptibility to astrocyte epigenetic memory formation. R

rs2304137 — Common variant that may affect ACLY activity. R

APOE

Apolipoprotein E is expressed in astrocytes and regulates lipid transport in the CNS. R

APOE4 allele is associated with impaired astrocyte function and increased Alzheimer's disease risk. R

APOE4 may compromise astrocyte ability to clear metabolic waste through glymphatic system. R

Astrocyte-specific APOE expression influences neuroinflammation and glial responses. R

rs429358 — The ε4 allele (Cys130Arg) associated with increased AD risk and astrocyte dysfunction. R

rs7412 — The ε2 allele (Arg176Cys) associated with reduced AD risk. R

More Research

Astrocyte memory is controlled by ATP-citrate lyase (ACLY), which produces acetyl-CoA used by p300 to control chromatin accessibility. R

ACLY+p300+ memory astrocytes are increased in acute and chronic EAE models, and their genetic inactivation ameliorates EAE. R

The pro-inflammatory memory phenotype is detected in human astrocytes in vitro and in chronic multiple sclerosis lesions. R

NR3C1 specifically limits the establishment of epigenetically-driven astrocyte pro-inflammatory memory early in life. R

NR3C1 target genes are associated with multiple sclerosis, providing a mechanistic link between early astrocyte programming and CNS inflammatory disorders later in life. R

Pro-inflammatory cis-regulatory elements are already accessible in NR3C1-deficient astrocytes by postnatal day 17 and persist into adulthood. R

IRF8 defines the epigenetic landscape in postnatal microglia, directing their transcriptome programs. R

PCGF1 in microglia alleviates neuroinflammation-mediated depressive behavior in adolescent mice through epigenetic regulation. R

Microglial epigenetic control is reviewed in detail, including trained immunity and epigenetic alterations in disease states. R

Astrocytes respond to all forms of central nervous system maladies. R

In a recent issue of Nature, Lee et al. demonstrate that astrocytes encode inflammatory stimuli as epigenetic memory, which strengthens responses to subsequent stimuli and exacerbates pathology in disease models. R

The glymphatic system is a brain-wide clearance pathway with CSF influx depending on aquaporin-4 (AQP4). R

AQP4-dependent glymphatic solute transport in the rodent brain has been validated across multiple laboratories. R

Astrocyte-derived VEGF-A drives blood-brain barrier disruption in CNS inflammatory disease. R

TNF-α plays a pivotal role in astrocyte activation and proliferation following LPS-mediated TLR2/4 activation. R

Co-stimulation with IL-1β and TNF-α induces a reactive astrocyte phenotype. R

GFAP is a well-established biomarker for TBI diagnosis and outcome prediction. R

For biomarker testing I use the Immune-zoomer to assess astrocyte activation markers and immune reactivity. R